"The U.S. Food and Drug Administration today approved Blincyto (blinatumomab) to treat patients with Philadelphia chromosome-negative precursor B-cell acute lymphoblastic leukemia (B-cell ALL), an uncommon form of ALL.
Precursor B-cell A"...
Mylotarg Consumer (continued)
In the US -
Call your doctor for medical advice about side effects. You may report side effects to FDA at 1-800-FDA-1088.
In Canada - Call your doctor for medical advice about side effects. You may report side effects to Health Canada at 1-866-234-2345.
Read the Mylotarg (gemtuzumab ozogamicin for injection) Side Effects Center for a complete guide to possible side effects
PRECAUTIONS: Consult your pharmacist.
Additional Mylotarg Information
Mylotarg - User Reviews
Report Problems to the Food and Drug Administration
Find out what women really need.